Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 504678, 8 pages
http://dx.doi.org/10.1155/2015/504678
Review Article

The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer’s Disease and Vascular Dementia

1Psychiatry Unit, Department of Medical and Surgical Sciences and Advanced Technologies, University Hospital Policlinico-Vittorio Emanuele, Santa Sofia Street 78, Catania, 95100 Sicily, Italy
2Department of “G.F. Ingrassia”, University Hospital Policlinico-Vittorio Emanuele, Santa Sofia Street 78, Catania, 95100 Sicily, Italy

Received 5 February 2015; Accepted 8 April 2015

Academic Editor: Verónica Pérez de la Cruz

Copyright © 2015 Maria Luca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Fiedorowicz and P. Grieb, “Nitrooxidative stress and neurodegeneration,” in Brain Damage—Bridging Between Basic Research and Clinics, A. Gonzalez-Quevedo, Ed., chapter 6, InTech, Rijeka, Croatia, 2012. View at Google Scholar
  2. V. J. Thannickal and B. L. Fanburg, “Reactive oxygen species in cell signaling,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1005–L1028, 2000. View at Google Scholar · View at Scopus
  3. S. Bolisetty and E. A. Jaimes, “Mitochondria and reactive oxygen species: physiology and pathophysiology,” International Journal of Molecular Sciences, vol. 14, no. 3, pp. 6306–6344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. P. Baran, M. M. Zeigler, S. Tridandapani, and C. B. Marsh, “The role of ROS and RNS in regulating life and death of blood monocytes,” Current Pharmaceutical Design, vol. 10, no. 8, pp. 855–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Ogino and D.-H. Wang, “Biomarkers of oxidative/nitrosative stress: an approach to disease prevention,” Acta Medica Okayama, vol. 61, no. 4, pp. 181–189, 2007. View at Google Scholar · View at Scopus
  6. H. Klandorf and K. van Dyke, “Oxidative and nitrosative stresses: their role in health and disease in man and birds,” in Oxidative Stress—Molecular Mechanisms and Biological Effects, V. Lushchak and H. M. Semchyshyn, Eds., chapter 3, InTech, Rijeka, Croatia, 2012. View at Publisher · View at Google Scholar
  7. H. Sies, “Oxidative stress: oxidants and antioxidants,” Experimental Physiology, vol. 82, no. 2, pp. 291–295, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. D. P. Jones, “Redefining oxidative stress,” Antioxidants and Redox Signaling, vol. 8, no. 9-10, pp. 1865–1879, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Ljubuncic, E. Gochman, and A. Z. Reznick, “Nitrosative stress in aging-its importance and biological implications in NF-kB signaling,” in Aging and Age-Related Disorders, S. Bondy and K. Maiese, Eds., vol. 3 of Oxidative Stress in Applied Basic Research and Clinical Practice, Springer, 2010. View at Google Scholar
  10. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Li, S. Horke, and U. Förstermann, “Vascular oxidative stress, nitric oxide and atherosclerosis,” Atherosclerosis, vol. 237, no. 1, pp. 208–219, 2014. View at Publisher · View at Google Scholar
  12. L. L. Torres, N. B. Quaglio, G. T. de Souza et al., “Peripheral oxidative stress biomarkers in mild cognitive impairment and alzheimer's disease,” Journal of Alzheimer's Disease, vol. 26, no. 1, pp. 59–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Gaspar, N. Milhazes, L. Santana, E. Uriarte, F. Borges, and M. J. Matos, “Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry,” Current Topics in Medicinal Chemistry, vol. 15, no. 5, pp. 432–445, 2015. View at Publisher · View at Google Scholar
  14. S. E. Browne, R. J. Ferrante, and M. F. Beal, “Oxidative stress in Huntington's disease,” Brain Pathology, vol. 9, no. 1, pp. 147–163, 1999. View at Google Scholar · View at Scopus
  15. E. Radi, P. Formichi, C. Battisti, and A. Federico, “Apoptosis and oxidative stress in neurodegenerative diseases,” Journal of Alzheimer's Disease, vol. 42, supplement 3, pp. S125–S152, 2014. View at Google Scholar
  16. C. Cervellati, A. Romani, D. Seripa et al., “Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia,” Journal of the Neurological Sciences, vol. 337, no. 1-2, pp. 156–161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan, “Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options,” Current Neuropharmacology, vol. 7, no. 1, pp. 65–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Allan Butterfield, B. Howard, S. Yatin et al., “Elevated oxidative stress in models of normal brain aging and Alzheimer's disease,” Life Sciences, vol. 65, no. 18-19, pp. 1883–1892, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Ball, “Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study,” Acta Neuropathologica, vol. 37, no. 2, pp. 111–118, 1977. View at Publisher · View at Google Scholar · View at Scopus
  20. R. H. Swerdlow, “Brain aging, Alzheimer's disease, and mitochondria,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1812, no. 12, pp. 1630–1639, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Price, P. B. Davis, J. C. Morris, and D. L. White, “The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease,” Neurobiology of Aging, vol. 12, no. 4, pp. 295–312, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-T. Chang, W.-N. Chang, N.-W. Tsai et al., “The roles of biomarkers of oxidative stress and antioxidant in alzheimer's disease: a systematic review,” BioMed Research International, vol. 2014, Article ID 182303, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-C. Badía, E. Giraldo, F. Dasí et al., “Reductive stress in young healthy individuals at risk of Alzheimer disease,” Free Radical Biology & Medicine, vol. 63, pp. 274–279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. K. Andersen, “Oxidative stress in neurodegeneration: cause or consequence?” Nature Medicine, vol. 10, pp. S18–S25, 2004. View at Google Scholar · View at Scopus
  25. L. Ghezzi, “Alzheimer's disease: clinical aspects and treatments,” in Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers, D. Galimberti and E. Scarpini, Eds., chapter 2, pp. 17–26, Springer, London, UK, 2014. View at Publisher · View at Google Scholar
  26. P. A. Adlard, B. A. Tran, D. I. Finkelstein et al., “A review of β-amyloid neuroimaging in Alzheimer's disease,” Frontiers in Neuroscience, vol. 8, article 327, 2014. View at Publisher · View at Google Scholar
  27. W. R. Markesbery, “The role of oxidative stress in Alzheimer disease,” Archives of Neurology, vol. 56, no. 12, pp. 1449–1452, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. D. A. Butterfield and C. M. Lauderback, “Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress,” Free Radical Biology and Medicine, vol. 32, no. 11, pp. 1050–1060, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. Yatin, S. Varadarajan, C. D. Link, and D. A. Butterfield, “In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1–42),” Neurobiology of Aging, vol. 20, no. 3, pp. 325–330, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Drake, C. D. Link, and D. A. Butterfield, “Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model,” Neurobiology of Aging, vol. 24, no. 3, pp. 415–420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Praticò, K. Uryu, S. Leight, J. Q. Trojanoswki, and V. M.-Y. Lee, “Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis,” The Journal of Neuroscience, vol. 21, no. 12, pp. 4183–4187, 2001. View at Google Scholar · View at Scopus
  32. S. Hee Lee, I. Kim, and B. Chul Chung, “Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease,” Clinical Biochemistry, vol. 40, no. 13-14, pp. 936–938, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Y. Aksenov, M. V. Aksenova, D. A. Butterfield, J. W. Geddes, and W. R. Markesbery, “Protein oxidation in the brain in Alzheimer's disease,” Neuroscience, vol. 103, no. 2, pp. 373–383, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Su, X. Wang, H.-G. Lee et al., “Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells,” Neuroscience Letters, vol. 468, no. 3, pp. 267–271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Tenreiro, K. Eckermann, and T. F. Outeiro, “Protein phosphorylation in neurodegeneration: friend or foe?” Frontiers in Molecular Neuroscience, vol. 7, article 42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Bhandary, A. Marahatta, H.-R. Kim, and H.-J. Chae, “An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 434–456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Gregersen and P. Bross, “Protein misfolding and cellular stress: an overview,” Methods in Molecular Biology, vol. 648, pp. 3–23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Shang and A. Taylor, “Ubiquitin-proteasome pathway and cellular responses to oxidative stress,” Free Radical Biology & Medicine, vol. 51, no. 1, pp. 5–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Higa and E. Chevet, “Redox signaling loops in the unfolded protein response,” Cellular Signalling, vol. 24, no. 8, pp. 1548–1555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Padurariu, A. Ciobica, R. Lefter, I. L. Serban, C. Stefanescu, and R. Chirita, “The oxidative stress hypothesis in Alzheimer's disease,” Psychiatria Danubina, vol. 25, no. 4, pp. 401–409, 2013. View at Google Scholar · View at Scopus
  41. R. Castellani, K. Hirai, G. Aliev et al., “Role of mitochondrial dysfunction in Alzheimer's disease,” Journal of Neuroscience Research, vol. 70, no. 3, pp. 357–360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Wang, W. Wang, L. Li, G. Perry, H.-G. Lee, and X. Zhu, “Oxidative stress and mitochondrial dysfunction in Alzheimer's disease,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 8, pp. 1240–1247, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Malm, M. Mariani, L. J. Donovan, L. Neilson, and G. E. Landreth, “Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation,” Journal of Neuroinflammation, vol. 12, no. 1, p. 7, 2015. View at Publisher · View at Google Scholar
  44. G. Dentesano, J. Serratosa, J. M. Tusell et al., “CD200R1 and CD200 expression are regulated by PPAR-γ in activated glial cells,” Glia, vol. 62, no. 6, pp. 982–998, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. D. M. Small, C. Morais, J. S. Coombes, N. C. Bennett, D. W. Johnson, and G. C. Gobe, “Oxidative stress-induced alterations in PPAR-γ and associated mitochondrial destabilization contribute to kidney cell apoptosis,” American Journal of Physiology—Renal Physiology, vol. 307, no. 7, pp. F814–F822, 2014. View at Publisher · View at Google Scholar
  46. J.-L. Tan, Q.-X. Li, G. D. Ciccotosto et al., “Mild oxidative stress induces redistribution of BACE1 in non-apoptotic conditions and promotes the amyloidogenic processing of Alzheimer's disease amyloid precursor protein,” PLoS ONE, vol. 8, no. 4, Article ID e61246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Miranda, C. Opazo, L. F. Larrondo et al., “The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease,” Progress in Neurobiology, vol. 62, no. 6, pp. 633–648, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Christen, “Oxidative stress and Alzheimer disease,” The American Journal of Clinical Nutrition, vol. 71, supplement 2, pp. 621S–629S, 2000. View at Google Scholar · View at Scopus
  49. M. A. Deibel, W. D. Ehmann, and W. R. Markesbery, “Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress,” Journal of the Neurological Sciences, vol. 143, no. 1-2, pp. 137–142, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. B. S. Berlett and E. R. Stadtman, “Protein oxidation in aging, disease, and oxidative stress,” The Journal of Biological Chemistry, vol. 272, no. 33, pp. 20313–20316, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Zhu, A. K. Raina, H.-G. Lee, G. Casadesus, M. A. Smith, and G. Perry, “Oxidative stress signalling in Alzheimer's disease,” Brain Research, vol. 1000, no. 1-2, pp. 32–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Rinaldi, M. C. Polidori, A. Metastasio et al., “Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease,” Neurobiology of Aging, vol. 24, no. 7, pp. 915–919, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Mangialasche, W. Xu, M. Kivipelto et al., “Tocopherols and tocotrienols plasma levels are associated with cognitive impairment,” Neurobiology of Aging, vol. 33, no. 10, pp. 2282–2290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. G. C. Román, “Vascular dementia: distinguishing characteristics, treatment, and prevention,” Journal of the American Geriatrics Society, vol. 51, supplement 5, pp. S296–S304, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Amar and G. Wilcock, “Vascular dementia,” British Medical Journal, vol. 312, no. 7025, pp. 227–231, 1996. View at Publisher · View at Google Scholar · View at Scopus
  56. I. Dias, M. Polidori, and H. Griffiths, “Hypercholesterolaemia-induced oxidative stress at the blood–brain barrier,” Biochemical Society Transactions, vol. 42, no. 4, pp. 1001–1005, 2014. View at Publisher · View at Google Scholar
  57. F. Derouiche, C. Bôle-Feysot, D. Naïmi, and M. Coëffier, “Hyperhomocysteinemia-induced oxidative stress differentially alters proteasome composition and activities in heart and aorta,” Biochemical and Biophysical Research Communications, vol. 452, no. 3, pp. 740–745, 2014. View at Publisher · View at Google Scholar
  58. S. Rubattu, B. Pagliaro, G. Pierelli et al., “Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress,” International Journal of Molecular Sciences, vol. 16, no. 1, pp. 823–839, 2015. View at Publisher · View at Google Scholar
  59. F. Di Lisa, N. Kaludercic, A. Carpi, R. Menabò, and M. Giorgio, “Mitochondria and vascular pathology,” Pharmacological Reports, vol. 61, no. 1, pp. 123–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. H. C. F. Oliveira, R. G. Cosso, L. C. Alberici et al., “Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria,” The FASEB Journal, vol. 19, no. 2, pp. 278–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Luc and J.-C. Fruchart, “Oxidation of lipoproteins and atherosclerosis,” The American Journal of Clinical Nutrition, vol. 53, no. 1, pp. 206S–209S, 1991. View at Google Scholar · View at Scopus
  62. M. C. Polidori, B. Frei, A. Cherubini et al., “Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke,” Free Radical Biology & Medicine, vol. 25, no. 4-5, pp. 561–567, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Gustaw-Rothenberg, K. Kowalczuk, and M. Stryjecka-Zimmer, “Lipids' peroxidation markers in Alzheimer's disease and vascular dementia,” Geriatrics & Gerontology International, vol. 10, no. 2, pp. 161–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Li, R. S. Willets, M. C. Polidori et al., “Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance,” Free Radical Research, vol. 44, no. 3, pp. 241–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Nanetti, R. Taffi, A. Vignini et al., “Reactive oxygen species plasmatic levels in ischemic stroke,” Molecular and Cellular Biochemistry, vol. 303, no. 1-2, pp. 19–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Raz, Q.-G. Zhang, C.-F. Zhou et al., “Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat,” PLoS ONE, vol. 5, no. 9, Article ID e12606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Nagayama, J. Lan, D. C. Henshall et al., “Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia,” Journal of Neurochemistry, vol. 75, no. 4, pp. 1716–1728, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. G. A. Rosenberg, N. Sullivan, and M. M. Esiri, “White matter damage is associated with matrix metalloproteinases in vascular dementia,” Stroke, vol. 32, no. 5, pp. 1162–1167, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. P. J. Kelly, J. D. Morrow, M. Ning et al., “Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study,” Stroke, vol. 39, no. 1, pp. 100–104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Chrissobolis and F. M. Faraci, “The role of oxidative stress and NADPH oxidase in cerebrovascular disease,” Trends in Molecular Medicine, vol. 14, no. 11, pp. 495–502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. M. L. Modrick, D. A. Kinzenbaw, Y. Chu, C. D. Sigmund, and F. M. Faraci, “Peroxisome proliferator-activated receptor-γ protects against vascular aging,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 302, no. 10, pp. R1184–R1190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Iadecola, “The pathobiology of vascular dementia,” Neuron, vol. 80, no. 4, pp. 844–866, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Ryglewicz, M. Rodo, P. K. Kunicki et al., “Plasma antioxidant activity and vascular dementia,” Journal of the Neurological Sciences, vol. 203-204, pp. 195–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. Á. Casado, M. E. López-Fernández, M. C. Casado, and R. de la Torre, “Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias,” Neurochemical Research, vol. 33, no. 3, pp. 450–458, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. R. N. Kalaria and C. Ballard, “Overlap between pathology of Alzheimer disease and vascular dementia,” Alzheimer Disease and Associated Disorders, vol. 13, no. 3, pp. S115–S123, 1999. View at Google Scholar · View at Scopus
  76. S. Bennett, M. M. Grant, and S. Aldred, “Oxidative stress in vascular dementia and alzheimer's disease: a common pathology,” Journal of Alzheimer's Disease, vol. 17, no. 2, pp. 245–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. B. H. Han, M. L. Zhou, A. W. Johnson et al., “Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 8, pp. E881–E890, 2015. View at Publisher · View at Google Scholar
  78. G. Paragh, P. Balla, E. Katona, I. Seres, A. Égerházi, and I. Degrell, “Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia,” European Archives of Psychiatry and Clinical Neuroscience, vol. 252, no. 2, pp. 63–67, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Esen, M. Aslan, M. E. Kucukoglu et al., “Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis,” Wiener Klinische Wochenschrift, 2015. View at Publisher · View at Google Scholar
  80. D. Litvinov, H. Mahini, and M. Garelnabi, “Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases,” North American Journal of Medical Sciences, vol. 4, no. 11, pp. 523–532, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Aviram and M. Rosenblat, “Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development,” Free Radical Biology & Medicine, vol. 37, no. 9, pp. 1304–1316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Commenges, V. Scotet, S. Renaud, H. Jacqmin-Gadda, P. Barberger-Gateau, and J.-F. Dartigues, “Intake of flavonoids and risk of dementia,” European Journal of Epidemiology, vol. 16, no. 4, pp. 357–363, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. O. Rozenberg, M. Rosenblat, R. Coleman, D. M. Shih, and M. Aviram, “Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice,” Free Radical Biology & Medicine, vol. 34, no. 6, pp. 774–784, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. L. T. McGrath, B. M. McGleenon, S. Brennan, D. McColl, S. McIlroy, and A. P. Passmore, “Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde,” QJM, vol. 94, no. 9, pp. 485–490, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Chaves, A. Toral, A. Bisonni et al., “Treatment with vitamin D and slowing of progression to severe stage of Alzheimer's disease,” Vertex, vol. 25, no. 114, pp. 85–91, 2014 (Spanish). View at Google Scholar
  86. K. H. Masaki, K. G. Losonczy, G. Izmirlian et al., “Association of vitamin E and C supplement use with cognitive function and dementia in elderly men,” Neurology, vol. 54, no. 6, pp. 1265–1272, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Zhang, A. Browne, D. Child, and R. E. Tanzi, “Curcumin decreases amyloid-β peptide levels by attenuating the maturation of amyloid-β precursor protein,” The Journal of Biological Chemistry, vol. 285, no. 37, pp. 28472–28480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. Y. Li, “Protective effects of curcumin on brain vascular dementia by chronic cerebral ischemia in rats and study of the molecular mechanism,” Alzheimer's & Dementia, vol. 7, no. 4, pp. e47–e48, 2011. View at Publisher · View at Google Scholar
  89. A. Clausen, X. Xu, X. Bi, and M. Baudry, “Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline,” Journal of Alzheimer's Disease, vol. 30, no. 1, pp. 183–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. X. R. Ma, Z. K. Sun, Y. R. Liu, Y. J. Jia, B. A. Zhang, and J. W. Zhang, “Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia,” Neural Regeneration Research, vol. 8, no. 22, pp. 2050–2059, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. M. J. Barrett, V. Alones, K. X. Wang, L. Phan, and R. H. Swerdlow, “Mitochondria-derived oxidative stress induces a heat shock protein response,” Journal of Neuroscience Research, vol. 78, no. 3, pp. 420–429, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. J. F. Abisambra, U. K. Jinwal, J. R. Jones, L. J. Blair, J. Koren III, and C. A. Dickey, “Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics,” Current Neuropharmacology, vol. 9, no. 4, pp. 623–631, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. J. R. Ou, M. S. Tan, A. M. Xie, J. T. Yu, and L. Tan, “Heat shock protein 90 in Alzheimer's disease,” BioMed Research International, vol. 2014, Article ID 796869, 7 pages, 2014. View at Publisher · View at Google Scholar
  94. Y. Chen, B. Wang, D. Liu et al., “Hsp90 chaperone inhibitor 17-AAG Attenuates Aβ-induced synaptic toxicity and memory impairment,” Journal of Neuroscience, vol. 34, no. 7, pp. 2464–2470, 2014. View at Publisher · View at Google Scholar · View at Scopus
  95. W. Luo, W. Sun, T. Taldone, A. Rodina, and G. Chiosis, “Heat shock protein 90 in neurodegenerative diseases,” Molecular Neurodegeneration, vol. 5, no. 1, article 24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Salminen, J. Ojala, K. Kaarniranta, M. Hiltunen, and H. Soininen, “Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease,” Progress in Neurobiology, vol. 93, no. 1, pp. 99–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Zou, Y. Guo, T. Guettouche, D. F. Smith, and R. Voellmy, “Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1,” Cell, vol. 94, no. 4, pp. 471–480, 1998. View at Publisher · View at Google Scholar · View at Scopus
  98. N. Fujikake, Y. Nagai, H. A. Popiel, Y. Okamoto, M. Yamaguchi, and T. Toda, “Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones,” The Journal of Biological Chemistry, vol. 283, no. 38, pp. 26188–26197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. N. V. Bobkova, D. G. Garbuz, I. Nesterova et al., “Therapeutic effect of exogenous Hsp70 in mouse models of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 38, no. 2, pp. 425–435, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. J. Agulla, D. Brea, F. Campos et al., “In vivo theranostics at the peri-infarct region in cerebral ischemia,” Theranostics, vol. 4, no. 1, pp. 90–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. G. A. Dienel, M. Kiessling, M. Jacewicz, and W. A. Pulsinelli, “Synthesis of heat shock proteins in rat brain cortex after transient ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 6, no. 4, pp. 505–510, 1986. View at Publisher · View at Google Scholar · View at Scopus
  102. J.-C. L. Plumier, A. M. Krueger, R. W. Currie, D. Kontoyiannis, G. Kollias, and G. N. Pagoulatos, “Transgenic mice expressing the human inducible Hsp70 have hippocampal neurons resistant to ischemic injury,” Cell Stress & Chaperones, vol. 2, no. 3, pp. 162–167, 1997. View at Publisher · View at Google Scholar · View at Scopus
  103. P. Papadopoulos, P. Rosa-Neto, J. Rochford, and E. Hamel, “Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology,” PLoS ONE, vol. 8, no. 7, Article ID e68612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. B. Sharma and N. Singh, “Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats,” Pharmacology Biochemistry and Behavior, vol. 100, no. 2, pp. 320–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. R. Ríos-Vázquez, R. Marzoa-Rivas, I. Gil-Ortega, and J. C. Kaski, “Peroxisome proliferator-activated receptor-γ agonists for management and prevention of vascular disease in patients with and without diabetes mellitus,” American Journal of Cardiovascular Drugs, vol. 6, no. 4, pp. 231–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. T. Persson, B. O. Popescu, and A. Cedazo-Minguez, “Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 427318, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus